Topical Azithromycin 1% in acute management of inflammatory pterygium
Accepted: 26 October 2011
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Wilms EB, Touw DJ, Heijerman HG. Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis. Ther Drug Monit 2006;28:219–25.
Kuper H, Wormald R. Topical azithromycin: New evidence. BJO 2007;91:556–67.
Verleden GM, Vanaudenaerde BM, Dupont LJ, Van Raemdonck DE. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006;174:566–70.
Aghai ZH, Kode A, Saslow JG, et al. Azithromycin suppresses activation of nuclear factor-кB and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants. Pediatr Res 2007;62:483–8.
Schleimer RP. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 1993;45 Suppl 1:S3–7.
Cheung PS , Si EC, Hosseini K. Anti-inflammatory Activity of Azithromycin as Measured by Its NF-кB Inhibitory Activity. Ocul Immunol Inflamm 2010;18:32–7.
Gray GC, McPhate DC, Leinonen M, et al. Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease. Clin Infect Dis 1998;26:103–10.
Chui J, Coroneo MT, Tat LT, et al. Ophthalmic Pterygium: A Stem Cell Disorder with Premalignant Features. Am J Pathol 2011;178:817-27.
Pan HW, Zhong JX, Jing CX. Comparison of Fibrin Glue versus Suture for Conjunctival Autografting in Pterygium Surgery: A Meta-Analysis. Ophthalmology 2011;118:1049-54.
Efron N, Morgan PB, Katsara SS. Validation of grading scales for contact lens complications. Ophthalmic Physiol Opt 2001;21:17-29.
Gazzard G, Saw SM, Farook M, et al. Pterygium in Indonesia: prevalence, severity and risk factors. Br J Ophthalmol 2002;86:1341–6.
Moran DJ, Hollows FC. Pterygium and ultraviolet radiation: a positive correlation. Br J Ophthalmol 1984;68:343–6.
Detels R, Dhir SP. Pterygium: a geographical study. Arch Ophthalmol 1967;78:485–91.
Lekhanont K, Rojanaporn D, Chuck RS, Vongthongsri A. Prevalence of dry eye in Bangkok, Thailand. Cornea 2006;25:1162–7.
Siak JJ, Ng SL, Seet LF, et al. The nuclear-factor кB pathway is activated in pterygium. Invest Ophthalmol Vis Sci 2011;52:230-6.
Luchs J. Efficacy of topical azithromycin ophthalmic solution intreatment of posterior blepharitis. Adv Ther 2008;25:858-70.
Bowman LM, Si E, Pang J, et al. Development of a topical polymeric mucoadhesive ocular delivery system for azithromycin. J Ocul Pharmacol Ther 2009;25:133-9.
Li DQ, Zhou N, Zhang L, et al. Suppressive Effects of Azithromycin on Zymosan-Induced Production of Proinflammatory Mediators by Human Corneal Epithelial Cells. Invest Ophthalmol Vis Sci 2010;51:5623–9.
Rojas J, Ma´laga H. Pterygium in Lima, Peru. Ann Ophthalmol 1986;18:147–9.
Ma K, Xu L, Jie Y, et al. Prevalence of and factors associated with pterygium in adult Chinese: the Beijing Eye Study. Cornea 2007;26:1184–6.
Supporting Agencies
NonePAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.